Just published in @TheLancet Oncology: Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma — an ESTRO study endorsed by EAU.
👉 Read the summary: https://t.co/rRjIs6EBnE
@Uroweb
Very visual presentations at #ESTRO24 discussing irradiated volume vs irradiating dose especially in the era of concurrent use of checkpoint inhibitors.
An image can speak a thousand words. In the realm of the field of #Reirradiation , though there is so much we dont know now, we can only know more when we collect data and share our information. Question is when can we realistically take that first step.....
July is #SarcomaAwarenessMonth!
We have an exciting month planned talking about working together across the global #sarcoma community and making a difference for patients.
Follow @sarcomapatients and like + share to help us reach as many people as possible.
#VoicesOfSarcoma
Latest #brainlab#RTelements 4.0 at #PWHOnc . Retreatment of brain mets included in a unique new workflow.
Keep track of old lesions and focus on new ones. 💪
See more at https://t.co/SfPWHPMO9Y
Our #lastpush as our show gets on the road! Come join us this coming #Wednesday to #Saturday as we take a deep dive into #contemporary#topics on #sarcomas. All welcome & registration is free! Further details can be found at our dedicated website https://t.co/nzy90vjlns
@herbloong@ayausc @KeckMedUSC @CUHKMedicine I can imagine the local Hong Kong AYA population will have much to gain if we were to make this a reality! @herbloong
#ESMOSarcoma20: Join us in Milan, on 3-5 Feb 2020, for three days of international networking and collaboration, featuring discussions with key opinion leaders in #sarcoma and #GIST. Time is running out to benefit from the best available rates 👉https://t.co/i95vgLiAbp
Thanks for the very practical and informative session with Prof Robert Coleman, @saxotomy , professor sookprasert on the new ESMO guidelines on bone health.
Rebound osteolysis - suggest a shot of zometa after stopping denosumab. Something worth to be aware of !#ESMOAsia19
CALL FOR PAPERS: Guest editor @herbloong will curate this special issue devoted to sarcomas. Visit the link to explore the suggested topics and submit a paper. Please submit by December 31, 2019 to be considered.
#JIPO#callforpapers#sarcomas
https://t.co/HuLNL0ZMnX